| 000 | 00695nam a2200289Ia 4500 | ||
|---|---|---|---|
| 999 |
_c12519 _d12519 |
||
| 001 | 003096 | ||
| 003 | OSt | ||
| 005 | 20201028104223.0 | ||
| 008 | 141222s9999 xx 000 0 und d | ||
| 020 | _a08915520 | ||
| 040 | _cDB/INS | ||
| 041 | 0 | _aeng | |
| 084 | _aWC100 | ||
| 084 | _bI3d V.3:3 | ||
| 245 | 0 | 0 | _aAntibacterial agents: Pharmacodynamics, pharmacology new agents |
| 245 | 0 | 0 | _ceditor Donald Kaye |
| 260 | _aPhiladelphia | ||
| 260 | _bW.B Saunders Company | ||
| 260 | _c1989 | ||
| 300 | _a669 | ||
| 300 | _bilus | ||
| 440 | 0 | _aInfectious disease of North America Vol. 3; No. 3 | |
| 650 | 1 | _aBacterias | |
| 700 | 1 | _aKaye, Donald | |
| 700 | 1 | _eed | |
| 942 |
_2NML _cMO |
||